A “HUGE” Investment Opportunity in Neurodegenerative and Mental Health Treatments
Neurodegenerative diseases and mental health are two key areas that continue to have a drastic impression on the healthcare system. Case in point, the neurodegenerative disease market is projected to reach a valuation of roughly US$44.90 billion by 2026, up from $39.24 billion in 2020 and is growing at a compound annual growth rate of 2.30 percent during the forecasted period. Stockhouse’s Jocelyn Aspa reports.
Weekly Update - Top Cannabis News Stories
1 | Top Story: Xebra Brands Ltd. begins formal THC cannabis cultivation in The Netherlands.
2 | Mindset Pharma Inc. to participate in the H.C. Wainwright BioConnect Conference.
3 | Aurora Cannabis Inc. delivers its largest ever medical cannabis shipment to Israel.
4 | HEXO Corp. appoints new board member and acting CFO.
5 | Hill Street Beverage Company appoints permanent CEO.
Top Cannabis Stocks | Dec 30, 2021 to Jan 5, 2022
1. T.HEXO | 34,724 | HEXO Corp.
2. TLRY | 18,930 | Tilray Inc.
3. T.WEED | 16,668 | Canopy Growth Corporation
4. C.TGIF | 10,087 | 1933 Industries Inc.
5. C.TNY | 8,263 | Tinley Beverage Company Inc.
6. T.AH | 7,784 | Aleafia Health Inc.
FULL DISCLOSURE: FSD Pharma Inc., Xebra Brands Ltd., and Mindset Pharma Inc. are clients of Stockhouse Publishing.
New to investing in Cannabis? Check out Stockhouse tips on How to Invest in Cannabis Stocks and some of our Top Cannabis Stocks.
For more of the latest info on Cannabis, check out the Cannabis Trending News hub. Or, for lively sector discussion, visit Stockhouse’s new Cannabis Bullboards page.